David R. Lynch

Neuroscience University of Pennsylvania, Philadelphia, PA, United States 
Neuroscience Biology
"David Lynch"
Mean distance: 26716.5


Sign in to add trainee
Elisa A. Waxman grad student 2006 Penn
Eric C. Deutsch grad student 2012 Penn
Amy J. Gleichman grad student 2012 Penn
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Johnson J, Mercado-Ayón E, Mercado-Ayón Y, et al. (2020) Mitochondrial dysfunction in the development and progression of neurodegenerative diseases. Archives of Biochemistry and Biophysics. 108698
Rodríguez-Pascau L, Britti E, Calap-Quintana P, et al. (2020) PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia. Neurobiology of Disease. 105162
Weng L, Laboureur L, Wang Q, et al. (2020) Extra-mitochondrial mouse frataxin and its implications for mouse models of Friedreich's ataxia. Scientific Reports. 10: 15788
Rummey C, Zesiewicz TA, Perez-Lloret S, et al. (2020) Test-retest reliability of the Friedreich's ataxia rating scale. Annals of Clinical and Translational Neurology
Rummey C, Farmer JM, Lynch DR. (2020) Predictors of loss of ambulation in Friedreich's ataxia. Eclinicalmedicine. 18: 100213
Rummey C, Corben LA, Delatycki MB, et al. (2019) Psychometric properties of the Friedreich Ataxia Rating Scale. Neurology. Genetics. 5: 371
Xiong E, Lynch AE, Corben LA, et al. (2019) Health related quality of life in Friedreich Ataxia in a large heterogeneous cohort. Journal of the Neurological Sciences. 410: 116642
Blair IA, Farmer J, Hersch S, et al. (2019) The current state of biomarker research for Friedreich's ataxia: a report from the 2018 FARA biomarker meeting. Future Science Oa. 5: FSO398
Weng L, Wang Q, Yu S, et al. (2019) Evaluation of antibodies for western blot analysis of frataxin protein isoforms. Journal of Immunological Methods
Patel M, Schadt K, McCormick A, et al. (2019) Open label Pilot Study of Oral Methylprednisolone for the Treatment of Patients with Friedreich Ataxia. Muscle & Nerve
See more...